Department of Cardiology, Huaian Medical District, General Hospital of Eastern Theater Command, No. 100 Jiankang East Road, Qingjiangpu District, Huaian City, Jiangsu Province, China.
Department of Cardiology, Huaian Medical District, General Hospital of Eastern Theater Command, No. 100 Jiankang East Road, Qingjiangpu District, Huaian City, Jiangsu Province, China.
Microvasc Res. 2022 Sep;143:104399. doi: 10.1016/j.mvr.2022.104399. Epub 2022 Jun 10.
BACKGROUND/AIMS: Myocardial ischemia-reperfusion injury leads to aggravated cardiac remodeling and heart failure. After myocardial infarction (MI), angiogenesis plays a vital role in the repair and regeneration of tissue. The purpose of the current study was to determine the effect of Tanshinone IIA (Tan IIA) on angiogenesis and elucidate its related mechanism.
The C57BL/6 mice MI model was established to evaluate the therapeutic effect of Tan IIA in vivo. MicroRNA (miRNA) microarray and bioinformatics analysis were performed to determine the differential expressions of miRNAs after Tan IIA administration. Cell proliferation, migration, and angiogenesis capacity were detected by EdU, Transwell, and Tube formation assay in vitro, respectively. The relationship between miR-499-5p (miR-499) and paired phosphate and tension homolog deleted on chromosome ten (PTEN) was confirmed by using a Dual-luciferase reporter assay.
Our results showed that Tan IIA administration improved cardiac function after MI by activating angiogenesis. Further miRNA microarray and bioinformatics analysis revealed that miR-499 was significantly down-regulated, while PTEN was remarkably upregulated after Tan IIA administration post-MI. In addition, we found that miR-499 knock-down effectively promotes cell proliferation, migration, and tube formation ability of HUVECs. Dual-luciferase reporter assay demonstrated that PTEN contains a direct binding site for miR-499-5p.
Tan IIA improves cardiac function post-MI by inducing angiogenesis. In terms of the mechanism, Tan IIA promotes therapeutic angiogenesis by regulating miR-499-5p/PTEN signaling pathway.
背景/目的:心肌缺血再灌注损伤导致心脏重构加重和心力衰竭。心肌梗死(MI)后,血管生成在组织修复和再生中起着至关重要的作用。本研究旨在探讨丹参酮 IIA(Tan IIA)对血管生成的影响,并阐明其相关机制。
建立 C57BL/6 小鼠 MI 模型,评估 Tan IIA 体内的治疗效果。通过 miRNA 微阵列和生物信息学分析,确定 Tan IIA 给药后 miRNA 的差异表达。通过 EdU、Transwell 和管形成试验分别检测细胞增殖、迁移和血管生成能力。通过双荧光素酶报告实验证实 miR-499-5p(miR-499)与第十号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)之间的关系。
我们的结果表明,Tan IIA 通过激活血管生成改善 MI 后的心功能。进一步的 miRNA 微阵列和生物信息学分析显示,Tan IIA 给药后 miR-499 明显下调,而 PTEN 明显上调。此外,我们发现 miR-499 敲低可有效促进 HUVECs 的细胞增殖、迁移和管形成能力。双荧光素酶报告实验证实,PTEN 含有 miR-499-5p 的直接结合位点。
Tan IIA 通过诱导血管生成改善 MI 后的心功能。就机制而言,Tan IIA 通过调节 miR-499-5p/PTEN 信号通路促进治疗性血管生成。